| 
			
			 People in their 50s with risk factors for cardiovascular disease - 
			including high blood pressure, high cholesterol or a history of 
			smoking - may benefit from starting a daily aspirin regimen and 
			staying on it for at least a decade, according to the U.S. 
			Preventive Services Task Force (USPSTF), a government-backed panel 
			of independent physicians. 
 A daily low-dose aspirin may also help protect against colorectal 
			cancer in people who are taking it to prevent heart attacks and 
			strokes.
 
 Because aspirin can cause bleeding in the stomach and brain, this 
			advice doesn’t apply to people with bleeding disorders.
 
 “As with any drug, patients and their doctors must balance the 
			benefits and risks of aspirin,” said USPSTF chair Dr. Kirsten 
			Bibbins-Domingo of the University of California, San Francisco.
 
 Adults aged 50 to 59 who have at least a 10 percent risk of having a 
			heart attack or stroke in the next decade can benefit the most from 
			taking 81 milligrams of aspirin a day, according to the new 
			guidelines.
 
 The American College of Cardiology provides an online risk 
			calculator here: http://bit.ly/1UEFYtE.
 
			
			 
			The advice doesn’t apply to people in their 60s because the bleeding 
			risk increases with age, however, and the jury is still out on 
			whether this approach makes sense for people under 50 or over 70, 
			the Task Force concluded.
 “Some people may benefit from aspirin more than others, which is why 
			there are several recommendations based on age,” Bibbins-Domino 
			added by email. The Task Force encourages people to talk with their 
			doctor about whether taking aspirin is appropriate, she said.
 
 Nearly 40 percent of U.S. adults over 50 already take aspirin to 
			prevent a first heart attack or avoid a second one, according a 
			research review published with the new guidelines in Annals of 
			Internal Medicine.
 
 But the Task Force is at odds with the U.S. Food and Drug 
			Administration, which has denied efforts by Bayer HealthCare LLC to 
			market aspirin for preventing heart attacks and strokes in people 
			with no history of cardiovascular disease.
 
 “All that aspirin does if your heart attack risk is really low is 
			cause you harm,” said Dr. Steven Nissen, who served on an FDA 
			advisory panel that recommended against widespread use of aspirin 
			for primary prevention and chairs the department of cardiovascular 
			medicine at the Cleveland Clinic in Ohio.
 
			
            [to top of second column] | 
 
			At least one in 10 people taking aspirin don’t need it, recent 
			research suggests.
 Patients can buy aspirin without a prescription, and doctors are 
			also free to put people on medicines for purposes that aren’t 
			approved by the FDA.
 
 The FDA did not respond to a request for comment by press time.
 
 Aspirin helps prevent blood cells called platelets from sticking 
			together and forming clots that clog arteries, leading to heart 
			attacks and strokes. The drug carries a bleeding risk because the 
			body also relies on platelet clusters to seal wounds by forming 
			scabs.
 
 Additionally, aspirin might lower the risk of colorectal cancer by 
			acting on a biochemical pathway these tumors need to grow, said Dr. 
			David Weinberg, chair of the department of medicine at Fox Chase 
			Cancer Center in Philadelphia.
 
 But patients shouldn’t take aspirin for cancer prevention, Weinberg, 
			who isn’t on the Task Force, said by email. Instead, they should 
			think of the reduced cancer risk as an added benefit if they already 
			need aspirin to address the risk of heart attacks and strokes.
 
 “For those persons already at higher risk for cardiovascular 
			disease, on balance aspirin is a good idea to reduce cardiovascular 
			disease risk alone,” Weinberg said. “However, it appears it will 
			also reduce colorectal cancer risk at the same time, which 
			represents a benefit with little or no additional risk if aspirin is 
			already indicated.”
 
 SOURCE: http://bit.ly/1i46lF7 Annals of Internal Medicine, online 
			April 11, 2016.
 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 |